Sign in
CompletedNo phase

Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs

Key facts

Who runs it
Alcon Research
Where
Houston, Kansas City, Mt. Pleasant, Salt Lake City, and Torrance, United StatesSee the 5 sites
Trial code
Status
Completed
People taking part
110 people enrolled
Started
14 Oct 2025
Ended
7 Oct 2026
Type of study
Interventional
Treatments tested
  • Clareon PanOptix Pro/Pro Toric Trifocal IOL
  • Phacoemulsification
Record updated
19 October 2026

Who can take part

Age
22 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Subjects with cataracts in both eyes, planned for removal by routine surgery (phacoemulsification)
  • Subject must be able to understand and sign an approved informed consent form
  • Subject is willing to complete all the required study visits for the duration of the study
  • Other protocol-defined inclusion criteria may apply

Who cannot take part

  • Previous intraocular or corneal surgery
  • Ocular conditions as specified in the protocol
  • Subjects who desire monovision correction
  • Other protocol-defined exclusion criteria may apply

Where in United States

  • Houston Eye AssociatesHouston, United States
  • Moyes Eye CenterKansas City, United States
  • Carolina Eyecare Physicians LLCMt. Pleasant, United States
  • The Eye Institute of UtahSalt Lake City, United States
  • Wolstan & Goldberg Eye AssociatesTorrance, United States

About the trial

What the trial wants to find out

The purpose of this study is to collect safety and performance data on two approved intraocular lenses (IOLs). This study will be conducted in participants who require cataract surgery in both eyes. The IOLs are designed to provide vision at far, arm's length, and near.

The group in the trial

  • Clareon PanOptix Pro/Pro Toric Trifocal IOLTreatment being tested

    The clouded lens will be removed by phacoemulsification, after which the PanOptix Pro and/or PanOptix Pro Toric IOLs will be implanted.

    Treatment: Clareon PanOptix Pro/Pro Toric Trifocal IOL and Phacoemulsification

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
19 October 2026